Division of Cancer Immunotherapy (Kashiwa), NCC

Japan

1 March 2019 - 29 February 2020

No articles found. Division of Cancer Immunotherapy (Kashiwa), NCC did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

National Cancer Center (NCC)

↳ Exploratory Oncology Research and Clinical Trial Center, NCC

↳ Division of Cancer Immunotherapy (Kashiwa), NCC

Division of Pathology, NCC

Division of Translational Research, NCC

Center for Cancer Control and Information Services, NCC

Center for Cancer Genomics and Advanced Therapeutics (C-CAT), NCC

Center for Public Health Sciences, NCC

Division of Epidemiology, NCC

National Cancer Center Hospital

Department of Breast and Medical Oncology, National Cancer Center Hospital

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital

Department of Genetic Medicine and Services, National Cancer Center Hospital

Department of Gynecology, National Cancer Center Hospital

National Cancer Center Hospital East

Division of Thoracic Oncology, NCC

Research Center for Innovative Oncology, NCC

National Cancer Center Research Institute (NCCRI)

Cancer Proteomics for Biomarker Development, NCC

Division of Cancer Differentiation, NCC

Division of Cancer Genomics, NCC

Division of Cancer Pathophysiology, NCC

Division of Chemotherapy and Clinical Research, NCC

Division of Epigenomics, NCC

Division of Genetics, NCC

Division of Genome Biology, NCC

Division of Hematological Malignancy, NCC

Division of Molecular Oncology, NCC

Division of Molecular and Cellular Medicine, NCC

Division of Refractory and Advanced Cancer, NCC

Fundamental Innovative Oncology Core Center (FIOC), NCC

Department of Clinical Genomics, NCC

Group for Frontier Science, NCC

Division of Rare Cancer Research, NCC

Laboratory of Fundamental Oncology, NCC

Research Center for Cancer Prevention and Screening, NCC

Tsuruoka Metabolomics Laboratory, NCC

Return to institution outputs

Latest supplement

Nature Index 2020 South Korea

A concerted government push to make South Korea an innovation leader, backed by strong investment and systemic reform, has brought rapid and long-lasting results. The country’s scientific landscape is becoming more diverse and more productive, as a place where upwardly mobile researchers thrive.

Access free